Cargando…
TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53
Resistance to chemotherapeutic drugs is a major obstacle in non-small cell lung cancer (NSCLC) therapy. The molecular determinants of NSCLC resistance to doxorubicin are unknown. In the present study, we investigated whether topoisomerase IIβ binding protein 1 (TopBP1) was involved in the chemoresis...
Autores principales: | Lv, Yinxiang, Huo, Yanan, Yu, Xican, Liu, Rongrong, Zhang, Shufen, Zheng, Xiaoxiao, Zhang, Xianning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042189/ https://www.ncbi.nlm.nih.gov/pubmed/27729767 http://dx.doi.org/10.2147/DDDT.S90705 |
Ejemplares similares
-
Cdks put Treslin on TopBP1
por: Short, Ben
Publicado: (2011) -
Expression of TopBP1 in hereditary breast cancer
por: Forma, Ewa, et al.
Publicado: (2012) -
TopBP1 and Claspin contribute to the radioresistance of lung cancer brain metastases
por: Choi, Seung Ho, et al.
Publicado: (2014) -
Cooperative activation of the ATR checkpoint kinase by TopBP1 and damaged DNA
por: Choi, Jun-Hyuk, et al.
Publicado: (2009) -
MDC1 collaborates with TopBP1 in DNA replication checkpoint control
por: Wang, Jiadong, et al.
Publicado: (2011)